Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Totally drug-resistant tuberculosis and adjunct therapies.

Journal of internal medicine - 1 Apr 2015

Parida S K, Axelsson-Robertson R, Rao M V, Singh N, Master I, Lutckii A, Keshavjee S, Andersson J, Zumla A, Maeurer M

Abstract excerpt

The first cases of totally drug-resistant (TDR) tuberculosis (TB) were reported in Italy 10 years ago; more recently, cases have also been reported in Iran, India and South Africa. Although there is no consensus on terminology, it is most commonly described as 'resistance to all first- and second...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Bacterial
Share to Extensively Drug-Resistant Tuberculosis
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Global Health

Share to Host-Pathogen Interactions

Share to Mycobacterium tuberculosis

Share to Nitroimidazoles

Share to Oxazolidinones

Source

Identifiers

PMID: 24809736
DOI: 10.1111/joim.12264

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24809736-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Totally drug-resistant tuberculosis and adjunct therapies.PMID 24809736Read ↗

Multidrug-resistant tuberculosis: a comprehensive review of pathogenesis, drug resistance, current treatment and future prospects.Semantic proximity Read ↗

The past, present and future of tuberculosis treatment.Semantic proximity Read ↗

Drug-Resistant Tuberculosis 2020: Where We StandSemantic proximity Read ↗

Drug resistance mechanisms and drug susceptibility testing for tuberculosis.Semantic proximity Read ↗

Mycobacterium Tuberculosis: Drug Resistance and Future PerspectivesSemantic proximity Read ↗

Mechanisms of drug resistance in mycobacterium tuberculosisSemantic proximity Read ↗

Drug-resistance mechanisms and tuberculosis drugs.Semantic proximity Read ↗

Mechanisms of drug resistance in <I>Mycobacterium tuberculosis</I>: update 2015Semantic proximity Read ↗

Drug‐resistant tuberculosis: Past, present, futureSemantic proximity Read ↗

Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.Semantic proximity Read ↗

[Emerging and drug-resistant infectious diseases--multi-drug resistant tuberculosis].Semantic proximity Read ↗

TB Anywhere, TB Everywhere. The First Case of pre-Extensively Drug Resistant Tuberculosis Treated with BPaL in Italy: Challenges and Opportunities for Transborder Collaboration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.